The immune activity of male severe or critical COVID‐19 patients from age group 7 was much lower than that of female patients not only in adaptive immunity (CD4.T and CD8.T) but also in innate immunity (mono) (Figure 2A‐C). This evidence concerns the gene CD4 and COVID-19.